PHARMARESEARCH BIO Co., Ltd. (XKON:217950)

South Korea flag South Korea · Delayed Price · Currency is KRW
32,850
-400 (-1.20%)
At close: Jun 10, 2026
Market Cap137.34B -22.9%
Revenue (ttm)178.19M -44.5%
Net Income-883.52M
EPS-22,088.06
Shares Out 4.18M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,571
Open33,750
Previous Close33,250
Day's Range31,900 - 33,750
52-Week Range25,000 - 42,950
Beta0.39
Analystsn/a
Price Targetn/a
Earnings Daten/a

About PHARMARESEARCH BIO

PharmaResearch BIO Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products worldwide. The company offers ReNTox injection for temporary improvement in the appearance of moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity in adult patients aged between 18 and 65. It is also developing Clostridium Botulinum Toxin type A, which is in Phase I clinical study for indications, including dynamic equinus foot deformity, upper limb spasticity, blepharospasm, etc. The co... [Read more]

Industry Pharmaceutical Preparations
Founded 2009
Country South Korea
Stock Exchange Korea New Exchange
Ticker Symbol 217950
Full Company Profile